Skip to Main Content

Paper Details

Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
J Infect Dis
0
2023
CD4, CD4+, CD4+ T-cell, Env, HIV, Participants, gp120, participants, subtype C gp120, subtype C gp120 Env protein
Author NameAffiliation
Kenneth H MayerKM Beth Israel Deaconess Medical Center, Harvard University, USA The Fenway Institute
Michael C KeeferMK University of Rochester
Ian FrankIF School of Medicine, University of Pennsylvania
Margaret Juliana McElrath
Margaret Juliana McElrathFred Hutchinson Cancer Center
  • 1 - 5

Datasets

Release 1.2